Nexpowder for Diverticular Bleeding Study
Part of Digestive system clinical trials.
This trial tests a powder called Nexpowder that is applied to stop bleeding from diverticula (small pouches) in the lower part of the digestive tract. It could be a treatment option for people who have active bleeding from these pouches.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years old or older.
- You must have been diagnosed with bleeding from diverticula in your lower digestive tract.
- You must not have bleeding in your upper digestive tract (stomach or esophagus).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication, PBK_M2502, in people who are scheduled for both an upper endoscopy and a colonoscopy. It aims to see if the medicine is safe and works well.
This pilot study tests whether a special powder, sprayed through an endoscope, can safely and effectively stop bleeding in the lower part of the digestive tract.
This trial tests a special pill that can be swallowed to help find the cause of anemia or hidden blood in the stool, without the need for more invasive tests. It is for patients who are already in the hospital and have been referred to a gastroenterologist.
This trial tests two medications—tranexamic acid and sucralfate—applied during an endoscopy (a camera procedure) to stop bleeding caused by tumors in the upper digestive tract. The goal is to see which treatment works better at controlling the bleeding.
This trial tests MBK-01, capsules made from healthy gut bacteria, to see if they can help people who keep getting diverticulitis. If you've had three or more bouts in the last three years, this study might offer a new treatment option.
This trial studies whether a device called Suprasorb CNPendo helps healing of certain full-thickness (through-and-through) injuries or wounds in the esophagus or rectum. It may be an option if your medical team is already considering negative pressure wound therapy for these specific problems.
Hear when a new Lower Gastrointestinal Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.